CSPG4 and Hepatic fibrosis: Finally, we verified the effects of NG2 on the underlying liver fibrosis process in vivo, through the injection of chemically modified and stable Cspg4 siRNA into MCDHF mice, since fatty liver injury has become a common cause of chronic liver disease globally [26,27].